relaxin-3
Selected indexed studies
- Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades. (Expert Opin Ther Pat, 2024) [PMID:38573177]
- The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease. (Int J Mol Sci, 2022) [PMID:35457203]
- Relaxin-3 systems in the brain--the first 10 years. (J Chem Neuroanat, 2011) [PMID:21693186]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades. (2024) pubmed
- The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease. (2022) pubmed
- Relaxin-3 systems in the brain--the first 10 years. (2011) pubmed
- Relaxin-3/insulin-like peptide 7, a neuropeptide involved in the stress response and food intake. (2010) pubmed
- Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain. (2017) pubmed
- Relaxin-3 Ameliorates Diabetic Cardiomyopathy by Inhibiting Endoplasmic Reticulum Stress. (2022) pubmed
- Relaxin-3, INSL5, and their receptors. (2008) pubmed
- Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases? (2014) pubmed
- Relaxin-3/RXFP3 Signaling and Neuroendocrine Function - A Perspective on Extrinsic Hypothalamic Control. (2013) pubmed
- The putative role of the relaxin-3/RXFP3 system in clinical depression and anxiety: A systematic literature review. (2021) pubmed